Literature DB >> 9178319

Maternal uniparental disomy of chromosome 2 and confined placental mosaicism for trisomy 2 in a fetus with intrauterine growth restriction, hypospadias, and oligohydramnios.

W F Hansen1, L E Bernard, S Langlois, K W Rao, N C Chescheir, A S Aylsworth, D I Smith, W P Robinson, I J Barrett, D K Kalousek.   

Abstract

We present a case of maternal uniparental heterodisomy for chromosome 2 (UPD 2) detected after trisomy 2 mosaicism was found on placental biopsy. This case presented prenatally with severe intrauterine growth restriction (IUGR) and oligohydramnios. The diploid newborn had hypospadias and features consistent with oligohydramnios sequence. He died shortly after birth of severe pulmonary hypoplasia. The term placenta had high levels of trisomy 2 in both the trophoblast and the stroma. A comparison of this case with others reported in the literature suggests that the IUGR and oligohydramnios are likely related to placental insufficiency due to the high levels of trisomy 2 present in the trophoblast of the term placenta and the presence of UPD 2 in the diploid placental line.

Entities:  

Mesh:

Year:  1997        PMID: 9178319     DOI: 10.1002/(sici)1097-0223(199705)17:5<443::aid-pd82>3.0.co;2-2

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

Review 1.  Confined placental mosaicism and intrauterine fetal growth.

Authors:  V S Lestou; D K Kalousek
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

2.  Donnai-Barrow syndrome (DBS/FOAR) in a child with a homozygous LRP2 mutation due to complete chromosome 2 paternal isodisomy.

Authors:  Sibel Kantarci; Nicola K Ragge; N Simon Thomas; David O Robinson; Kristin M Noonan; Meaghan K Russell; Dian Donnai; F Lucy Raymond; Christopher A Walsh; Patricia K Donahoe; Barbara R Pober
Journal:  Am J Med Genet A       Date:  2008-07-15       Impact factor: 2.802

3.  Recurrent Trisomies: Chance or Inherited Predisposition?

Authors:  J E Ulm
Journal:  J Genet Couns       Date:  1999-04       Impact factor: 2.537

4.  Retinal dystrophy due to paternal isodisomy for chromosome 1 or chromosome 2, with homoallelism for mutations in RPE65 or MERTK, respectively.

Authors:  Debra A Thompson; Christina L McHenry; Yun Li; Julia E Richards; Mohammad I Othman; Eberhard Schwinger; Douglas Vollrath; Samuel G Jacobson; Andreas Gal
Journal:  Am J Hum Genet       Date:  2001-11-27       Impact factor: 11.025

5.  Maternal uniparental heterodisomy with partial isodisomy of a chromosome 2 carrying a splice acceptor site mutation (IVS9-2A>T) in ALS2 causes infantile-onset ascending spastic paralysis (IAHSP).

Authors:  Thilo Herzfeld; Nicole Wolf; Pia Winter; Holger Hackstein; Daniel Vater; Ulrich Müller
Journal:  Neurogenetics       Date:  2008-09-23       Impact factor: 2.660

6.  Uniparental Disomy of Chromosome 2 Unmasks New ITGA6 Recessive Mutation and Results in a Lethal Junctional Epidermolysis Bullosa in a Newborn.

Authors:  Rebecca Higgins; Annika N Jensen; Julian Wachstein; Leena Bruckner-Tuderman; Roland Spiegel; Hubert Traber; Josef Achermann; Martin Schaller; Birgit Fehrenbacher; Martin Röcken; Desislava Ignatova; Yun-Tsan Chang; Tina Fischer; Agnes E Schwieger-Briel; Lars E French; Wolfram Hoetzenecker; René Hornung; Andreas Malzacher; Antonio Cozzio; Alexander Navarini; Cristina Has; Emmanuella Guenova
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875

7.  Chromosomal Microarray Analysis for the Fetuses with Aortic Arch Abnormalities and Normal Karyotype.

Authors:  Xiaoqing Wu; Ying Li; Linjuan Su; Xiaorui Xie; Meiying Cai; Na Lin; Hailong Huang; Yuan Lin; Liangpu Xu
Journal:  Mol Diagn Ther       Date:  2020-10       Impact factor: 4.074

8.  Contribution of uniparental disomy in a clinical trio exome cohort of 2675 patients.

Authors:  Lei Wang; Pengfei Liu; Weimin Bi; Teresa Sim; Xia Wang; Magdalene Walkiewicz; Magalie Sophie Leduc; Linyan Meng; Fan Xia; Christine M Eng; Yaping Yang; Bo Yuan; Hongzheng Dai
Journal:  Mol Genet Genomic Med       Date:  2021-09-29       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.